Actively Recruiting
Randomized Study Comparing Continuous Versus Intermittent Zanubrutinib Maintenance Therapy After Initial Treatment in Older Adults With Untreated Mantle Cell Lymphoma
Led by Alliance for Clinical Trials in Oncology · Updated on 2026-11-03
421
Participants Needed
242
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating whether continuous or intermittent use of zanubrutinib after achieving complete remission with rituximab is effective for older adults with mantle cell lymphoma MCL who have not been treated before. This phase III trial aims to compare the time to disease progression or death between continuous zanubrutinib treatment and intermittent treatment restarted at progression. The study also assesses overall survival, response rates, adverse events, quality of life, and cognitive function in these patients. Participants first receive induction therapy with zanubrutinib taken orally twice daily and rituximab given intravenously once every 28 days for up to six cycles. Those who achieve complete remission are then randomly assigned to one of two maintenance groups continuous zanubrutinib treatment or observation with zanubrutinib restarted upon disease progression. Throughout the trial, patients undergo imaging tests such as PETCT, CT, or MRI scans, bone marrow biopsies, and may have endoscopy or colonoscopy as clinically indicated. Blood samples may also be collected. During the study, participants will be regularly monitored with scans and laboratory tests to track disease status and side effects. Quality of life and symptom burden are evaluated using questionnaires. After completing treatment, patients are followed every six months for up to ten years to assess long-term outcomes. The primary outcome is progression-free survival measured up to ten years from randomization.
CONDITIONS
Brief Title
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Research Team
A
Anne Beaven, MD
D
Destin Carlisle
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here